Health product recall

Glucagon (2021-09-25)

Starting date:
September 25, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-76509

Last updated:
2021-09-27

Summary

  • Product:
    Glucagon

Reason

Eli Lilly is recalling lot D239382A to the retail level because of a product complaint reporting that the vial of Glucagon was in liquid form instead of the powder

Depth of distribution

Retailers

Affected products

Glucagon

DIN, NPN, DIN-HIM

DIN 02243297

Dosage form

Powder for solution, kit

Strength

Glucagon (Recombinant DNA Origin) 1mg/vial

Lot or serial number

D239382A

Companies

Recalling Firm

Eli Lilly Canada Inc.

130 King Street West, Exchange Tower, Suite 900

Toronto

M5X 1B1

Ontario

CANADA

Marketing Authorization Holder

Eli Lilly Canada Inc.

130 King Street West, Exchange Tower, Suite 900

Toronto

M5X 1B1

Ontario

CANADA